- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0241337

Classio Life Sciences Private Limited
About Classio Life Sciences Private Limited
Data last updated:
Classio Life Sciences Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 January 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2022PTC207889.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sonali Ramraje Musale and Swati Kailash Ambhure.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No: 4 Shri Chakrdhar Heights Ambegaon Bk. Gavthan Near Zp School, Pune, Maharashtra, India – 411046.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.62 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹1.86 Lakh (net margin -28.1%) and EBITDA of -₹2.48 Lakh (EBITDA margin -37.5%).
Classio Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0241337).
Company details
Recognitions & Rankings of Classio Life Sciences
Contact details
Classio Life Sciences Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressShop No: 4 Shri Chakrdhar Heights Ambegaon Bk. Gavthan Near Zp School, Pune, Maharashtra, India – 411046
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Classio Life Sciences are manufacturing and wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations and wholesale trade, except of motor vehicles and motorcycles. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | |
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Classio Life Sciences Private Limited, buy the company report.
Financials of Classio Life Sciences Private Limited
FY 2025 filings availableClassio Life Sciences Private Limited reported revenue of ₹6.62 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA rose 1% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.48 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.86 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -37.5% | |||
| Net Profit Margin | -28.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Classio Life Sciences Private Limited, buy the company report.
Board of directors of Classio Life Sciences Private Limited
Classio Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonali Ramraje Musale | Director | 06 Sep 2023 | 3 Years 2 Months | Current |
| Swati Kailash Ambhure | Director | 21 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Classio Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Flyvet Pharmaceuticals Private Limited | ₹7.05 Lakh (FY 2024) | Jind, Haryana, India | ||||
| Indrani Healthcare Private Limited | ₹7.04 Lakh (FY 2025) | Noida, Uttar Pradesh, India | ||||
| A3r Pharma Private Limited | ₹6.98 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Eupid Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2025) | 16.0% | Dadri, Uttar Pradesh, India | |||
| Aerolyma Private Limited | ₹6.63 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Classio Life Sciences Private Limitedthis company | ₹6.62 Lakh (FY 2025) | -₹1.86 Lakh | -28.1% | -6.0% | Pune, Maharashtra, India | |
| Sree Mathilakam Food Products Private Limited | ₹6.54 Lakh (FY 2025) | 167.0% | Malayinkil, Kerala, India | |||
| Oncure Drugs Private Limited | ₹6.4 Lakh (FY 2024) | -64.0% | Mumbai, Maharashtra, India | |||
| Medicean Pharmaceuticals Private Limited | ₹6.23 Lakh (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India | |||
| Sood Paper and Allied Chemicals Private Limited | ₹6.2 Lakh (FY 2024) | 1.0% | Mumbai, Maharashtra, India | |||
| Madhurhealth and Nutrition Private Limited | ₹6.16 Lakh (FY 2025) | -20.0% | Pune, Maharashtra, India |
To see the full peer comparison of Classio Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Classio Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Classio Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Classio Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Classio Life Sciences Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Sonali Ramraje Musale was appointed as Director on 06 Sep 2023.
Frequently asked questions
Classio Life Sciences is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 January 2022 (4+ years old) and is registered under CIN U24230PN2022PTC207889.
Classio Life Sciences has 2 current directors:
- Sonali Ramraje Musale - Director
- Swati Kailash Ambhure - Director
The latest financial statements of Classio Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Classio Life Sciences is U24230PN2022PTC207889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Classio Life Sciences was incorporated on 21 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Classio Life Sciences by revenue are Flyvet Pharmaceuticals Private Limited, Indrani Healthcare Private Limited, A3r Pharma Private Limited, Eupid Pharmaceuticals Private Limited, Aerolyma Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Sonali Ramraje Musale was appointed as Director on 06 Sep 2023. Yash Arun Kamathe ceased to be Director on 06 Sep 2023. Swati Kailash Ambhure was appointed as Director on 21 Jan 2022.
Yes, Classio Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0241337).
The registered office of Classio Life Sciences is at Shop No: 4 Shri Chakrdhar Heights Ambegaon Bk. Gavthan Near Zp School, Pune, Maharashtra, India – 411046.
Classio Life Sciences operates in the chemicals industry, in the manufacturing segment.
Classio Life Sciences can be reached at its registered office: Shop No: 4 Shri Chakrdhar Heights Ambegaon Bk. Gavthan Near Zp School, Pune, Maharashtra, India – 411046.

